Tiziana Life Sciences (TLSA) Total Current Liabilities (2017 - 2025)

Tiziana Life Sciences has reported Total Current Liabilities for 9 years, with the latest figure at $11.2 million in Q4 2025.

• On a quarterly basis, Total Current Liabilities rose 52.54% year-over-year to $11.2 million in Q4 2025; TTM through Dec 2025 was $11.2 million, a 52.54% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 52.54% from the prior year.
• Total Current Liabilities was $11.2 million for Q4 2025 at Tiziana Life Sciences, up from $7.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $11.2 million in Q4 2025, with the low at $6.5 million in Q4 2023.
• Average Total Current Liabilities over 5 years is $7.9 million, with a median of $7.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities dropped 11.7% in 2022, then jumped 52.54% in 2025.
• Over 5 years, Total Current Liabilities stood at $7.5 million in 2021, then slipped by 11.7% to $6.7 million in 2022, then retreated by 1.86% to $6.5 million in 2023, then climbed by 12.37% to $7.3 million in 2024, then surged by 52.54% to $11.2 million in 2025.
• The last three Total Current Liabilities figures came in at $11.2 million (Q4 2025), $7.3 million (Q4 2024), and $6.5 million (Q4 2023), per Business Quant data.